OKT3 After Lung Transplantation

OKT3® (monoclonal antibody)


OKT3 is an immunosuppressive medicine that helps prevent organ rejection.


Administered intravenously only.

Adults: Usually receive 5 to 10mg per day over 7 to 14 days.
Children: Usually receive 2.5 to 5 mg per day over 7 to 14 days.


The transplant team orders the medication and it will be administered by the nurse during your hospitalization.

Common Side Effects

Fever, chills, flu-like symptoms, shortness of breath, headache, low blood pressure, joint pain, diarrhea.